Your browser doesn't support javascript.
loading
Pharmacokinetics and tolerability of paritaprevir, a direct acting antiviral agent for hepatitis C virus treatment, with and without ritonavir in healthy volunteers.
Menon, R M; Klein, C E; Podsadecki, T J; Chiu, Y-L; Dutta, S; Awni, W M.
Affiliation
  • Menon RM; Clinical Pharmacokinetics and Pharmacodynamics, AbbVie, 1 North Waukegan Road, AP31-3, North Chicago, Illinois, 60064.
  • Klein CE; Clinical Pharmacokinetics and Pharmacodynamics, AbbVie, 1 North Waukegan Road, AP31-3, North Chicago, Illinois, 60064.
  • Podsadecki TJ; Infectious Diseases, R48U, AP-30, AbbVie, 1 North Waukegan Road, North Chicago, Illinois, 60064.
  • Chiu YL; Department of Biometrics, AbbVie, 1 North Waukegan Road, AP31-2, North Chicago, Illinois, 60064.
  • Dutta S; Clinical Pharmacokinetics and Pharmacodynamics, AbbVie, 1 North Waukegan Road, AP31-3, North Chicago, Illinois, 60064.
  • Awni WM; Clinical Pharmacology and Pharmacometrics, AbbVie, 1 North Waukegan Road, R4PD AP31-3, North Chicago, IL, 60064, USA.
Br J Clin Pharmacol ; 81(5): 929-40, 2016 May.
Article in En | MEDLINE | ID: mdl-26710243
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents / Ritonavir / Hepatitis C, Chronic / Macrocyclic Compounds / Cytochrome P-450 CYP3A Inhibitors Type of study: Clinical_trials Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Br J Clin Pharmacol Year: 2016 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents / Ritonavir / Hepatitis C, Chronic / Macrocyclic Compounds / Cytochrome P-450 CYP3A Inhibitors Type of study: Clinical_trials Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Br J Clin Pharmacol Year: 2016 Type: Article